Breaking News

Germany Defeats Argentina for Fourth World Cup Title
Tweet TWEET

BSD Medical to Present at The 15th Annual Rodman & Renshaw Global Investment Conference on September 9, 2013

  BSD Medical to Present at The 15th Annual Rodman & Renshaw Global Investment
  Conference on September 9, 2013

Presentation to be webcast live on Monday, September 9, at 10:00 a.m. Eastern

Rodman & Renshaw Global Investment Conference 2013

Business Wire

SALT LAKE CITY -- September 5, 2013

BSD Medical (NASDAQ: BSDM) today announced it will be featured as a presenting
company at the 15^th Annual Rodman & Renshaw Global Investment Conference,
sponsored by H.C. Wainwright & Co., LLC. The investor conference is being
heldSeptember 8-10, 2013, at the Millennium Broadway Hotel in New York City.

William Barth, BSD Medical’s Chief Financial Officer, will provide an overview
of BSD's business during the live presentation and will be available to
participate in one-on-one meetings with institutional investors who are
registered to attend the conference. The presentation will be webcast live. To
access the webcast, please visit either the Events & Presentations tab on
BSD’s website at http://investor.bsdmedical.com/events_and_presentations or
www.rodm.com. The webcast replay will remain available for 90 days following
the live presentation.

“We are looking forward to attending our first institutional investor
conference following our recently completed non-deal roadshow as we continue
to broaden our institutional exposure,” stated William Barth, Chief Financial
Officer of BSD Medical.

Event: 15^th Annual Rodman & Renshaw Global Investment Conference

Date: September 9, 2013

Presentation Time: 10:00 a.m. Eastern Time

Location: Room 7.01; Millennium Broadway Hotel in New York City

About BSD Medical Corporation

BSD Medical Corporation develops, manufactures, markets and services systems
to treat cancer and benign diseases using heat therapy delivered using focused
radiofrequency (RF) and microwave energy. BSD’s product lines include both
hyperthermia and ablation treatment systems. BSD’s hyperthermia cancer
treatment systems, which have been in use for several years in the United
States, Europe and Asia, are used to treat certain tumors with heat
(hyperthermia), while increasing the effectiveness of other therapies such as
radiation therapy. BSD’s microwave ablation system has been developed as a
stand-alone therapy to employ precision-guided microwave energy to ablate
(destroy) soft tissue. The Company has developed extensive intellectual
property, multiple products in the market and established distribution in the
United States, Europe and Asia. Certain of the Company’s products have
received regulatory approvals and clearances in the United States, Europe and
China. For further information visit BSD Medical's website at
www.BSDMedical.com.

Statements contained in this press release that are not historical facts are
forward-looking statements, as defined in the Private Securities Litigation
Reform Act of 1995. All forward-looking statements are subject to risks and
uncertainties detailed in the Company's filings with the Securities and
Exchange Commission. These forward-looking statements speak only as of the
date on which such statements are made, and the Company undertakes no
obligation to update such statements to reflect events or circumstances
arising after such date.

Contact:

BSD Medical Corporation
William (Bill) S. Barth, 801-972-5555
investor@bsdmc.com
or
Financial Profiles
Tricia Ross, 916-939-7285
tross@finprofiles.com